Arraying autoantibodies in SLE - lessons learned

Current Molecular Medicine

Volumn 15, Issue 5, 2015, Pages 456-461

  Wang, L ^a,b   Mohan, C ^b   Li, Q Z ^b  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoantibody profiling; Biomarker; High throughput assay; Proteomic microarray; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; BETA 2 MICROGLOBULIN; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; BIOLOGICAL MARKER;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNODIFFUSION; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICROARRAY; NONHUMAN; PROTEOMIC MICROARRAY; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING; ANIMAL; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; PROCEDURES; PROTEIN MICROARRAY; PROTEOMICS; STANDARDS;

ANIMALS; AUTOANTIBODIES; BIOMARKERS; HUMANS; IMMUNOASSAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 84938604225     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524015666150630124649     Document Type: Article

References (54)

1. [1] Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25.
2. [2] Fauci AS, Braunwald E, Kasper DL, et al., Eds. Harrison's Principles of Internal Medicine. 17th ed. New York: McGraw-Hill Publishing 2005.
3. [3] Croca S, Bassett P, Chambers S, et al. IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. Arthritis Res Ther 2015; 17(1): 26.
4. [4] Heinlen LD, McClain MT, Merrill J, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007; 56: 2344-51.
5. [5] Holman HR, Deicher HR, Kunkel HG. The L. E. cell and the L. E. serum factors. Bull N Y Acad Med 1959; 35: 409-18.
6. [6] Frodlund M, Dahlstrom O, Kastbom A, Skogh T, Sjowall C. Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open 2013; 3(10): e003608.
7. [7] Chareonsirisuthigul T, Khositnithikul R, Intaramat A, et al. Performance comparison of immunodiffusion, enzyme-linked immunosorbent assay, immunochromatography and hemagglutination for serodiagnosis of human pythiosis. Diagn Microbiol Infect Dis 2013; 76(1): 42-5.
8. [8] Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med 2014; 12: 38.
9. [9] Krause C, Ens K, Fechner K, et al. EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics. Lupus 2015; 24(4-5): 516-29.
10. [10] Tan EM. Antinuclear antibodies defining autoimmunity pathways. Arthritis Res Ther 2014; 16(1): 104.
11. [11] Kurien BT, D'Sousa A, Bruner BF, et al. Prolidase deficiency breaks tolerance to lupus-associated antigens. Int J Rheum Dis 2013; 16(6): 674-80.
12. [12] Ching KH, Burbelo PD, Tipton C, et al. Two major autoantibody clusters in systemic lupus erythematosus. PLoS One 2012; 7(2): e32001.
13. [13] Vazquez-Del Mercado M, Palafox-Sanchez CA, Munoz-Valle JF, et al. High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus. Arthritis Res Ther 2010; 12: R6.
14. [14] Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205: 3007-18.
15. [15] Scofield RH. Do we need new autoantibodies in lupus? Arthritis Res Ther 2010; 12: 120.
16. [17] Lood C, Tyden H, Gullstrand B, et al. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus. PLoS One 2015; 10(4): e0125109.
17. [18] Hadaschik EN, Wei X, Leiss H, et al. Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease. Arthritis Res Ther 2015; 17(1): 35.
18. [19] Sinclair D, Saas M, Williams D, Hart M, Goswami R. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs. Clin Lab 2007; 53: 183-91.
19. [20] Abdulahad DA, Westra J, Bijzet J, et al. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther 2011; 13: R71.
20. [21] Jiang C, Deshmukh US, Gaskin F, et al. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J Immunol 2010; 184: 1085-91.
21. [22] Alaiya A, Assad L, Alkhafaji D, et al. Proteomic analysis of Class IV lupus nephritis. Nephrol Dial Transplant 2015; 30(1): 62-70.
22. [23] Kazemipour N, Qazizadeh H, Sepehrimanesh M, Salimi S. Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus. Lupus 2015; 24(6): 582-7.
23. [24] Somparn P, Hirankarn N, Leelahavanichkul A, et al. Urinary proteomics revealed prostaglandin H(2)D-isomerase, not Zn-a2-glycoprotein, as a biomarker for active lupus nephritis. J Proteomics 2012; 75(11): 3240-7.
24. [25] Katsumata Y, Kawaguchi Y, Baba S, et al. Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches. Mol Cell Proteomics 2011; 10(6): M110.005330.
25. [26] Yeste A, Quintana FJ. Antigen microarrays for the study of autoimmune diseases. Clin Chem 2013; 59(7): 1036-44.
26. [27] Tassinari OW, Caiazzo RJ Jr, Ehrlich JR, Liu BC. Identifying autoantigens as theranostic targets: antigen arrays and immunoproteomics approaches. Curr Opin Mol Ther 2008; 10(2): 107-15.
27. [28] Graham KL, Vaysberg M, Kuo A, Utz PJ. Autoantigen arrays for multiplex analysis of antibody isotypes. Proteomics 2006; 6: 5720-4.
28. [29] Robinson WH, DiGennaro C, Hueber W, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002; 8: 295-301.
29. [30] Becker AM, Dao KH, Han BK, et al. SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One 2013; 8(6): e67003.
30. [31] Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001; 2: RESEARCH0004.
31. [32] MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000; 289: 1760-3.
32. [33] Tavares RM, Turer EE, Liu CL, et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 2010; 33: 181-91.
33. [34] Culton DA, Nicholas MW, Bunch DO, et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 2007; 27: 53-68.
34. [35] Silverman GJ, Srikrishnan R, Germar K, et al. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol 2008; 153: 10216.
35. [36] Graham KL, Robinson WH, Steinman L, Utz PJ. High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases. Autoimmunity 2004; 37: 269-72.
36. [37] Sekine H, Graham KL, Zhao S, et al. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus. J Immunol 2006; 177: 7423-34.
37. [38] Thibault DL, Graham KL, Lee LY, et al. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther 2009; 11: R112.
38. [39] Fattal I, Shental N, Mevorach D, et al. An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology 2010; 130: 337-43.
39. [40] Li QZ, Xie C, Wu T, et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 2005; 115: 3428-39.
40. [41] Liu K, Li QZ, Yu Y, et al. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun 2007; 8: 634-45.
41. [42] Li QZ, Zhou J, Wandstrat AE, et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol 2007; 147: 60-70.
42. [43] Li QZ, Zhou J, Lian Y, et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol 2010; 159: 281-91.
43. [44] Li QZ, Karp DR, Quan J, et al. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther 2011; 13: R38.
44. [45] Olsen NJ, Li QZ, Quan J, Wang L, Mutwally A, Karp DR. Autoantibody profiling to follow evolution of lupus syndromes. Arthritis Res Ther 2012; 14(4): R174.
45. [46] Price JV, Haddon DJ, Kemmer D, et al. Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest 2013; 123(12): 5135-45.
46. [47] Kattah MG, Alemi GR, Thibault DL, Balboni I, Utz PJ. A new two-color Fab labeling method for autoantigen protein microarrays. Nat Methods 2006; 3: 745-51.
47. [48] El Khoury G, Laurenceau E, Chevolot Y, et al. Development of miniaturized immunoassay: influence of surface chemistry and comparison with enzyme-linked immunosorbent assay and Western blot. Anal Biochem 2010; 400: 10-8.
48. [49] Trune DR, Larrain BE, Hausman FA, Kempton JB, MacArthur CJ. Simultaneous measurement of multiple ear proteins with multiplex ELISA assays. Hear Res 2011; 275(1-2): 1-7.
49. [50] Martins TB, Burlingame R, von Muhlen CA, et al. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004; 11: 1054-9.
50. [51] Hartmann M, Roeraade J, Stoll D, Templin MF, Joos TO. Protein microarrays for diagnostic assays. Anal Bioanal Chem 2009; 393: 1407-16.
51. [52] Wolf-Yadlin A, Sevecka M, MacBeath G. Dissecting protein function and signaling using protein microarrays. Curr Opin Chem Biol 2009; 13: 398-405.
52. [53] Schweitzer B, Roberts S, Grimwade B, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol 2002; 20: 359-65.
53. [54] Huusko JM, Karjalainen MK, Mahlman M, et al. A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia. BMC Med Genet 2014; 15: 120.
54. [55] Ma Z, Ni X, Zhang W, et al. Hexagonal Ag nanoarrays induced enhancement of blue light emission from amorphous oxidized silicon nitride via localized surface plasmon coupling. Opt Express 2014; 22(23): 28180-9.